Bahrain
Bahrain: Sotrovimab used to treat over 200 COVID-19 patients
![](/wp-content/uploads/2021/07/Sotrovimab-improves-the-condition-of-97-of-Corona-patients-in-1200x900-1-780x470.jpg)
On Sunday, Bahrain’s Ministry of Health announced positive results from two weeks of Sotrovimab use.
It is a new anti-viral therapy that has been approved for use on patients with severe attack of COVID-19. The therapy was used in over 230 patients from 18 June to 1 July.
![](/wp-content/uploads/2021/07/210603590_2954251398190240_2148127770009196381_n-867x1024.jpg)
Sotrovimab is developed by British pharmaceutical company, GlaxoSmithKline (GSK) and Vir Biotechnology, a clinical immunology therapy developer.